Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

ALLI vs ALMOTRIPTAN MALATE: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

ALLI vs ALMOTRIPTAN MALATE: Safety Overview

Metric ALLI ALMOTRIPTAN MALATE
Total FAERS Reports 1,057 497
Deaths Reported 0 3
Death Rate N/A 0.6%
Hospitalizations 14 60
Average Patient Age 46.7 yrs 52.4 yrs
% Female Patients N/A 16.5%
FDA Approval Date N/A Jul 7, 2015
Manufacturer N/A Mylan Pharmaceuticals Inc.
Route N/A ORAL
Marketing Status N/A Discontinued